Taisho Pharmaceutical R&D

Taisho Pharmaceutical is a leading Japanese pharmaceutical company headquartered in Tokyo, specializing in both over-the-counter (OTC) medicines and prescription pharmaceuticals. The company holds a dominant position in the Japanese OTC market with iconic brands like Lipovitan-D and Pabron, while its R&D division focuses on metabolic diseases, infectious diseases, and central nervous system disorders. Taisho actively pursues a hybrid business model, leveraging strong domestic consumer healthcare presence alongside a growing ethical drug pipeline developed through internal research and strategic global partnerships. The company is currently expanding its international footprint, particularly in Southeast Asia and Europe, through acquisitions and licensing agreements.